R13P (p.Arg13Pro) variant of KRT4 (Keratin, type II cytoskeletal 4)

R13P (p.Arg13Pro) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

R13P (p.Arg13Pro) variant details